» Articles » PMID: 11803512

Examination of Genetic Linkage of Chromosome 15 to Schizophrenia in a Large Veterans Affairs Cooperative Study Sample

Overview
Journal Am J Med Genet
Specialty Genetics
Date 2002 Jan 23
PMID 11803512
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have reported genetic linkage evidence for a schizophrenia gene on chromosome 15q. Here, chromosome 15 was examined by genetic linkage analysis using 166 schizophrenia families, each with two or more affected subjects. The families, assembled from multiple centers by the Department of Veterans Affairs Cooperative Study Program, consisted of 392 sampled affected subjects and 216 affected sibling pairs. By DSM-III-R criteria, 360 subjects (91.8%) had a diagnosis of schizophrenia and 32 (8.2%) were classified as schizo-affective disorder, depressed. Participating families had diverse ethnic backgrounds. The largest single group were northern European American families (n = 62, 37%), but a substantial proportion was African American kindreds (n = 60, 36%). The chromosome 15 markers tested were spaced at intervals of approximately 10 cM over the entire chromosome and 2-5 cM for the region surrounding the alpha-7 nicotinic cholinergic receptor subunit gene (CHRNA7). These markers were genotyped and the data analyzed using semiparametric affecteds-only linkage analysis. In the European American families, there was a maximum Z-score of 1.65 between markers D15S165 and D15S1010. These markers are within 1 cM from CHRNA-7, the site previously implicated in schizophrenia. However, there was no evidence for linkage to this region in the African America kindreds.

Citing Articles

The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders.

Di Lascio S, Fornasari D, Benfante R Int J Mol Sci. 2022; 23(7).

PMID: 35408823 PMC: 8998457. DOI: 10.3390/ijms23073463.


A novel knockout mouse for the small EDRK-rich factor 2 (Serf2) showing developmental and other deficits.

Cleverley K, Lee W, Mumford P, Collins T, Rickman M, Cunningham T Mamm Genome. 2021; 32(2):94-103.

PMID: 33713180 PMC: 8012326. DOI: 10.1007/s00335-021-09864-6.


Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia.

Tregellas J, Wylie K Nicotine Tob Res. 2018; 21(3):349-356.

PMID: 30137618 PMC: 6379034. DOI: 10.1093/ntr/nty034.


The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Sinkus M, Graw S, Freedman R, Ross R, Lester H, Leonard S Neuropharmacology. 2015; 96(Pt B):274-88.

PMID: 25701707 PMC: 4486515. DOI: 10.1016/j.neuropharm.2015.02.006.


Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Dai D, Wang Y, Yuan J, Zhou X, Jiang D, Li J Biomed Rep. 2014; 2(5):729-736.

PMID: 25054019 PMC: 4106624. DOI: 10.3892/br.2014.308.